Kingworld Medicines Group falls 5% in Hong Kong tradingMarket Movers·Nov 10, 2026 at 07:12 AM01110-1.32%
GWO: Record earnings and 19.4% ROE underpin 2027 growth and capital returnsQuartr·Nov 5, 2026 at 04:21 PM01110-1.32%
Kingworld Medicines H1 profit drops 33.9% to RMB 7.56 million; revenue falls 32% to RMB 275.37 millionPUBT·Aug 27, 2026 at 12:47 PM01110-1.32%
The HK Pharma M&A Playbook: Is It Any Different This Time?Global Report·Aug 15, 2026 at 09:42 AM01110-1.32%
Kingworld Medicines schedules board meeting to review interim results, consider dividendPUBT·Aug 14, 2026 at 12:02 PM01110-1.32%
Kingworld Medicines GroupSigns MOU to Pursue Exclusive Distribution Rights for Two Lingnan Formula ProductsPR Newswire·Jun 15, 2026 at 05:08 AM01110-1.32%
Kingworld Medicines Warns of Sharp 2025 Profit Decline Despite Second-Half RecoveryTip Ranks·Mar 24, 2026 at 01:12 PM01110-1.32%
The corruption investigation by the ICAC reveals that the former general manager of a pharmaceutical company defrauded service fees of HKD 1.1 million; two individuals have pleaded guilty and are awaiting sentencingAASTOCKS·Feb 11, 2026 at 02:11 AMGMECS精准医-2.35%
"Nin Jiom Pei Pa Koa" agent anticipates acquisition involving a well-known pharmaceutical company in Hong Kong, ready for a second spring at any time | Li ShengyangStheadline·Feb 1, 2026 at 01:13 AM01110-1.32%
KINGWORLD released its interim results, with a loss attributable to shareholders of 5.412 million yuan, turning from profit to loss year-on-yearZhitong·Aug 27, 2025 at 02:01 PM01110-1.32%
KINGWORLD issued a profit warning, expecting a loss attributable to owners of approximately HKD 4.5 million in the first half of the year, a year-on-year turnaround from profit to lossZhitong·Aug 21, 2025 at 02:09 PM01110-1.32%
KINGWORLD: Zhang Jianbin resigns as independent non-executive directorZhitong·Aug 3, 2025 at 10:23 AM01110-1.32%